Search

Your search keyword '"Teo SH"' showing total 419 results

Search Constraints

Start Over You searched for: Author "Teo SH" Remove constraint Author: "Teo SH"
419 results on '"Teo SH"'

Search Results

1. The Great Mimic Again? A Case of Tuberculosis Knee

3. A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2

4. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

5. Been, being and becoming : the meaning of change

6. Polygenic risk modeling for prediction of epithelial ovarian cancer risk (vol 30, pg 349, 2021)

7. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

8. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

9. Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

10. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

11. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

12. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

14. Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting

15. Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium

16. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

17. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

18. Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

19. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

20. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

21. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

22. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.

25. Two truncating variants in FANCC and breast cancer risk

26. Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry

27. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

28. Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations

29. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

30. The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium

31. The BRCA2 c.68‐7T > A variant is not pathogenic:a model for clinical calibration of spliceogenicity

33. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

34. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

35. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

36. Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

37. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

38. Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study

39. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

40. rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

41. Fine-mapping of the 1p11.2 breast cancer susceptibility locus

42. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

43. Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)

44. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

45. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

46. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

47. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

48. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus

49. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

50. rs2735383, located at a microRNA binding site in the 3 ' UTR of NBS1, is not associated with breast cancer risk

Catalog

Books, media, physical & digital resources